Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 3
1994 2
1995 2
1998 3
1999 3
2000 3
2001 6
2002 8
2003 7
2004 4
2005 6
2006 5
2007 9
2008 6
2009 4
2010 7
2011 10
2012 8
2013 5
2014 8
2015 7
2016 13
2017 15
2018 13
2019 3
2020 13
2021 8
2022 13
2023 15
2024 18
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Results by year

Filters applied: . Clear all
Page 1
Empagliflozin in Patients with Chronic Kidney Disease.
The EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R. The EMPA-KIDNEY Collaborative Group, et al. N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4. N Engl J Med. 2023. PMID: 36331190 Free PMC article. Clinical Trial.
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.
EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Agrawal N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Zhu D, Dayanandan R, Arimoto R, Mayne KJ, Ng SYA, Sammons E, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney DZI, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Massey D, Brueckmann M, Landray MJ, Baigent C, Haynes R; EMPA-KIDNEY Collaborative Group. EMPA-KIDNEY Collaborative Group, et al. N Engl J Med. 2025 Feb 20;392(8):777-787. doi: 10.1056/NEJMoa2409183. Epub 2024 Oct 25. N Engl J Med. 2025. PMID: 39453837 Free PMC article. Clinical Trial.
Monocytes in Uremia.
Girndt M, Trojanowicz B, Ulrich C. Girndt M, et al. Toxins (Basel). 2020 May 21;12(5):340. doi: 10.3390/toxins12050340. Toxins (Basel). 2020. PMID: 32455723 Free PMC article. Review.
Pflege Kolleg 9 — Hygiene Im Alltag.
Girndt M, Hübner NO, Podbielski A. Girndt M, et al. Procare. 2021;26(8):29-42. doi: 10.1007/s00735-021-1393-7. Epub 2021 Oct 26. Procare. 2021. PMID: 34728906 Free PMC article. German. No abstract available.
[Waiting list management].
Pein U, Fritz A, Girndt M. Pein U, et al. Among authors: girndt m. Urologe A. 2020 Jan;59(1):10-16. doi: 10.1007/s00120-019-01090-y. Urologe A. 2020. PMID: 31853891 Review. German.
High-Dose Glucocorticoids for the Treatment of Sudden Hearing Loss.
Plontke SK, Girndt M, Meisner C, Fischer I, Böselt I, Löhler J, Ludwig-Kraus B, Richter M, Steighardt J, Reuter B, Böttcher C, Langer J, Pethe W, Seiwerth I, Jovanovic N, Großmann W, Kienle-Gogolok A, Boehm A, Neudert M, Diensthuber M, Müller A, Dazert S, Guntinas-Lichius O, Hornung J, Vielsmeier V, Stadler J, Rahne T; HODOKORT Trial Investigators. Plontke SK, et al. Among authors: girndt m. NEJM Evid. 2024 Jan;3(1):EVIDoa2300172. doi: 10.1056/EVIDoa2300172. Epub 2023 Dec 26. NEJM Evid. 2024. PMID: 38320514 Clinical Trial.
[Electrolyte disorders].
Girndt M. Girndt M. Internist (Berl). 2011 Aug;52(8):963-74; quiz 975. doi: 10.1007/s00108-011-2819-2. Internist (Berl). 2011. PMID: 21681474 Review. German.
207 results